溴隐亭与左旋多巴对帕金森病疗效的比较。
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
作者信息
Godwin-Austen R B, Smith N J
出版信息
J Neurol Neurosurg Psychiatry. 1977 May;40(5):479-82. doi: 10.1136/jnnp.40.5.479.
Abstract
The effects of bromocriptine and levodopa were compared in a blind trial in 18 patients with Parkinson's disease. Optimal doses of the two drugs were given in identical capsules: there was no significant difference between the therapeutic effects. There were wide individual differences in response to the two drugs. Side effects were more common with bromocriptine because of side effects.
摘要
在一项针对18名帕金森病患者的盲法试验中，对溴隐亭和左旋多巴的效果进行了比较。将两种药物的最佳剂量装入相同的胶囊中给药：两种药物的治疗效果没有显著差异。个体对这两种药物的反应存在很大差异。由于副作用，溴隐亭的副作用更为常见。
相似文献
1
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.溴隐亭与左旋多巴对帕金森病疗效的比较。
J Neurol Neurosurg Psychiatry. 1977 May;40(5):479-82. doi: 10.1136/jnnp.40.5.479.
2
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.溴隐亭的研究。第2部分。与左旋多巴治疗特发性帕金森病的双盲对照研究。
Neurology. 1976 Jun;26(6 PT 1):511-3. doi: 10.1212/wnl.26.6.511.
3
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.多巴胺激动剂辅助治疗帕金森病：溴隐亭和CU 32 - 085的开放试验
J Neurol. 1982;227(2):75-88. doi: 10.1007/BF00313773.
4
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.卡麦角林用于接受左旋多巴治疗的晚期帕金森病患者的临床经验。
Drugs. 1998;55 Suppl 1:17-22. doi: 10.2165/00003495-199855001-00003.
5
An ergot derivative in the treatment of Parkinson's disease.一种用于治疗帕金森病的麦角衍生物。
Postgrad Med J. 1976;52suppl 1:81-5.
6
Treatment of parkinson's disease with bromocriptine.用溴隐亭治疗帕金森病。
N Engl J Med. 1976 Dec 16;295(25):1400-4. doi: 10.1056/NEJM197612162952504.
7
Studies with bromocriptine. Part 1. "On-off" phenomena.溴隐亭的研究。第1部分。“开-关”现象。
Neurology. 1976 Jun;26(6 PT 1):508-10. doi: 10.1212/wnl.26.6.508.
8
Treatment of Parkinson's disease with dopamine agonists: a review.多巴胺激动剂治疗帕金森病：综述
Am J Med Sci. 1979 Jul-Aug;278(1):65-76. doi: 10.1097/00000441-197907000-00008.
9
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.溴隐亭治疗帕金森病：长期治疗、剂量反应及与左旋多巴的比较。
J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1101-8. doi: 10.1136/jnnp.39.11.1101.
10
Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.左旋多巴治疗的帕金森病患者中溴隐亭与安慰剂的对比研究
Acta Neurol Scand. 1977 Sep;56(3):269-73.
引用本文的文献
1
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.帕金森病的神经保护与治疗策略：最新观点
Int J Mol Sci. 2016 Jun 8;17(6):904. doi: 10.3390/ijms17060904.
2
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.多巴胺激动剂辅助治疗帕金森病：溴隐亭和CU 32 - 085的开放试验
J Neurol. 1982;227(2):75-88. doi: 10.1007/BF00313773.
3
Audit of the drug treatment of Parkinson's disease in general practice.全科医疗中帕金森病药物治疗的审计
J R Coll Gen Pract. 1985 Jun;35(275):276-8.
4
Bromocriptine in Parkinsonism.溴隐亭治疗帕金森病
Br Med J. 1978 May 27;1(6124):1402-4. doi: 10.1136/bmj.1.6124.1402.
5
Bromocriptine in the treatment of parkinsonism.溴隐亭治疗帕金森症
Drugs. 1979 May;17(5):365-82. doi: 10.2165/00003495-197917050-00006.
本文引用的文献
1
Bromocriptine in Parkinsonism.帕金森病中的溴隐亭
Br Med J. 1974 Nov 23;4(5942):442-4. doi: 10.1136/bmj.4.5942.442.
2
Effects of L-dopa in Parkinson's disease.
Lancet. 1969 Jul 26;2(7613):165-8. doi: 10.1016/s0140-6736(69)91417-2.
3
Bromocriptine treatment in Parkinson's disease.帕金森病的溴隐亭治疗
J Neurol Neurosurg Psychiatry. 1976 Feb;39(2):184-93. doi: 10.1136/jnnp.39.2.184.
Zotero 插件